Sano is developing a wearable device that continuously monitors blood glucose and other metabolic activity, with the company describing the first product as a completely painless, non‑invasive glucose monitor. The company has kept most technical details under wraps and is not disclosing how the sensor works. Sano plans to launch its first product early next year and intends to use aggregated user data to help people understand how foods and behaviors affect their glucose and metabolism. The approach targets consumers broadly, not only people with diabetes, by providing personalized metabolic feedback. Sano has a team of about 20 employees and says the recent funding will be used to grow the team aggressively ahead of the launch. Financially, the company secured seed capital to support product development and go‑to‑market buildout.

Total raised

$10M

Funding rounds

1

Latest round

Seed

Latest activity

Jun 2015